PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Astragaloside IV enhanced cardiac function indicators, including left ventricular ejection fraction [PMID:37854719].
Traditional Chinese patent medicines (which may include this herb) were evaluated in a meta-analysis of 191 trials, though specific efficacy for A. propinquus alone was not detailed in the abstract [PMID:17463317].
A compound containing A. propinquus relieved cisplatin-induced acute kidney injury [PMID:32004631].
Combined use with Salvia miltiorrhiza reduced infarcted myocardium area and protected cardiac function [PMID:36699092].
Dried roots regulated transmembrane iron transporters and ferroptosis-related factors [PMID:35958925].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 34217844 (2021) — Effects of dietary Astragalus Propinquus Schischkin polysaccharides on growth performance, immunological parameters, antioxidants responses and inflammation-related gene expression in Channa argus. · Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
- 2.PMID: 32004631 (2020) — Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation. · Journal of ethnopharmacology
- 3.PMID: 37783132 (2023) — The effects of astragaloside IV on gut microbiota and serum metabolism in a mice model of intracerebral hemorrhage. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 4.PMID: 36034875 (2022) — Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verification. · Frontiers in pharmacology